How to Search Data in BIOINFILE
Finding specific biological data can be a challenge. This post demonstrates BIOINFILE's intuitive new search functionality, which translates your data requests into actionable parameters. Watch the demo to learn how to quickly find the -omics data you are looking for.
RedIA Salud
Spain’s agency Red.es is launching a €50 million call to strengthen AI in the health sector. We explain how to position yourself at a time when data quality and its long-term viability are decisive factors.
White Paper: Financial Benefits of Database Outsourcing
Discover how outsourcing scientific reference databases can drastically cut R&D costs, speed up product development, and free internal teams from time-consuming curation tasks. This analysis reveals the financial impact of BIOINFILE’s approach to reference data curation.
Use Case: Calibrated Database for Vaginal and Endometrial Microbiome
BIOINFILE helped a diagnostics company upgrade its microbiota analysis with a calibrated, ALCOA++ compliant database, cutting ambiguous reads, boosting species and pathogen detection, and delivering sharper, more reliable results.
Activa Startups
Activa Startups is a program supported by the Spanish Ministry of Industry and the EOI Foundation, aimed at fostering open innovation through collaboration between SMEs and startups, offering grants of up to €9,500 for innovative projects. Bioinfile can be a valuable partner for SMEs, especially those focused on microbiome research, by providing technical expertise in database optimization and bioinformatics analysis.
Crafting GOOD DATA
Just like a jeweler carefully shapes a diamond, data curation in biotech requires the same precision and expertise. At BIOINFILE, we help companies optimize their microbiome data, transforming it into a finely crafted tool ready for innovation. Want to learn how we're helping companies streamline knowledge transfer and stay competitive?
Emerging Trends in Responsible AI and Synthetic DNA in the USA
In this article, we talk about the intersection of AI and synthetic DNA from the responsible-AI perspective. More specifically, we provide a summary of the framework of actions that is taking place in the USA along with an Executive Order from the White House, to prevent biotechnological risks associated with the misuse of AI tools.
SILVA Enters into the Global Biodata Coallition
The Global Biodata Coalition recently announced the inclusion of SILVA into its prestigious Global Core Biodata Resources (GCBRs) list, which now includes 52 top-tier data resources in life sciences and biomedical research globally.
AI Risk classification in Europe
Everyone attentive as the EU has just established the world's first rules for AI. The Commission addresses the risks of AI and classifies them into four categories: unacceptable, high, limited and minimal risk.
Ureterostomy, utis and metagenomics
How can metagenomics improve Urinary Tract Infections (UTIs) for ureterostomized patients? A paper by Huang et. al., 2023.
Lactobacillus isalae
Lactobacillus isalae sp. nov. recently published under the ISALA intitiative (University of Antwerp). Adding +1 species to the Human Vaginal Microbiota catalogue.